Table 1.
Patients with acute coronary syndrome admitted to our centre from March 13 to April 9, 2020, compared with the same time period in 2019
| Variable | 2020 | 2019 | P value |
|---|---|---|---|
| Patients admitted with ACS, n | 92 | 45 | – |
| Patients transferred from spoke centers | 56 (61%) | 9 (20%) | < 0.001 |
| Age, y, mean ± SD | 65 ± 13 | 66 ± 13 | 0.67 |
| Males | 70 (76%) | 35 (78%) | 0.83 |
| STEMI | 57 (62%) | 23 (51%) | 0.23 |
| NSTE-ACS | 35 (38%) | 22 (49%) | 0.23 |
| High-risk NSTE-ACS | 7 (8%) | 4 (9%) | 0.80∗ |
| Coronary angiography/PCI | 86 (93%) | 43 (96%) | 0.99∗ |
| Positive COVID-19 swab at admission | 9 (10%) | – | – |
| Cardiogenic shock | 12 (13%) | 3 (7%) | 0.38∗ |
| Cardiogenic shock in COVID-19 patients | 1 (1.1%) | – | – |
| In-hospital cardiac death | 9 (10%) | 2 (4%) | 0.33∗ |
| In-hospital cardiac death in COVID-19 patients | 1 (1.1%) | – | – |
| In-hospital death due to COVID-19 | 0 (0%) | – | – |
Results are presented as n (%) unless otherwise specified.
ACS, acute coronary syndrome; COVID-19, Coronavirus disease 2019; NSTE-ACS, Non-ST-elevation acute coronary syndrome; PCI, percutaneous coronary intervention; STEMI, ST-elevation acute myocardial infarction.
∗
Fisher exact test.